Not applicableStudy completedNCT03488368What this trial is testingLongterm Renal Oucomes of STOP-IgAN Trial ParticipantsWho this might be right forIgA Nephropathy RWTH Aachen University 148
Testing effectiveness (Phase 2)Study completedNCT05834738What this trial is testingRandomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA NephropathyWho this might be right forIgA NephropathyImmunoglobulin A Nephropathy Novartis Pharmaceuticals 54
Early research (Phase 1)Study completedNCT05398510What this trial is testingEvaluate the Safety, Tolerability and Pharmacokinetics Pharmacodynamics of SHR-2010 by Intravenously/Subcutaneously in Healthy SubjectWho this might be right forIgA Nephropathy Guangdong Hengrui Pharmaceutical Co., Ltd 61
Early research (Phase 1)Looking for participantsNCT07305116What this trial is testingCAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune DiseaseWho this might be right forAutoimmune DiseasesSystemic Lupus Erthematosus (SLE)Multi-Drug Resistant Nephrotic Syndrome+3 more The Children's Hospital of Zhejiang University School of Medicine 15
Post-approval studies (Phase 4)Study completedNCT00863252What this trial is testingMycophenolate Mofetil for IgA NephropathyWho this might be right forIGA Nephropathy The University of Hong Kong 40
Not applicableStudy completedNCT02529722What this trial is testingBiomarkers for the Progression of IgA NephropathyWho this might be right forIgA NephropathyGlomerular Diseases Istanbul University 120
Early research (Phase 1)Study completedNCT06004947What this trial is testingA Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant MedicationsWho this might be right forAnti-neutrophil Cytoplasmic Antibody-associated Vasculitis Amgen 32
Early research (Phase 1)Study completedNCT06490991What this trial is testingComparison of HRS-5965 Capsules and Tablets in Healthy SubjectsWho this might be right forParoxysmal Nocturnal Hemoglobinuria，IgA Nephropathy Chengdu Suncadia Medicine Co., Ltd. 16
Testing effectiveness (Phase 2)Study completedNCT01224028What this trial is testingEvaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy PatientsWho this might be right forIgA Nephropathy Astellas Pharma Inc 40
Post-approval studies (Phase 4)UnknownNCT04020328What this trial is testingLeflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal InsufficiencyWho this might be right forGlomerulonephritis, IGARenal Insufficiency, Chronic Shenzhen Second People's Hospital 70
Testing effectiveness (Phase 2)Study completedNCT00396721What this trial is testingSirolimus Therapy for Poor Prognosis Immunoglobulin A NephropathyWho this might be right forGlomerulonephritis, IGANephropathy, IGAIGA Nephropathy Josep m Cruzado 23
Not applicableStudy completedNCT01269021What this trial is testingAn Multi-site Prospective Study to Assess the Efficacy and Safety of MMF in the Treatment of Proliferative IgA Nephropathy(IgAN)Who this might be right forIgA Nephropathy (IgAN) Zhi-Hong Liu, M.D. 176
Not applicableNot Yet RecruitingNCT07649538What this trial is testingMediators of Loin Pain in IgA NephropathyWho this might be right forIgA Nephropathy (IgAN) University of Leicester 40
Early research (Phase 1)Study completedNCT06922305What this trial is testingRelative Bioavailability Study of HR19042 in Healthy SubjectsWho this might be right forPrimary IgA Nephropathy; Autoimmune Hepatitis Jiangsu HengRui Medicine Co., Ltd. 18
Post-approval studies (Phase 4)Study completedNCT00755859What this trial is testing"Steroids and Azathioprine Versus Steroids Alone in IgAN"Who this might be right forIGA Nephropathy A. Manzoni Hospital 206
Testing effectiveness (Phase 2)Study completedNCT05016323What this trial is testingEvaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy.Who this might be right forIgA Nephropathy Jiangsu HengRui Medicine Co., Ltd. 316
Testing effectiveness (Phase 2)WithdrawnNCT02605525What this trial is testingEfficacy and Safety of SM101 in the Treatment of IgA NephropathyWho this might be right forImmunoglobulin A Nephropathy Baxalta now part of Shire
Testing effectiveness (Phase 2)Looking for participantsNCT07375758What this trial is testingMIL116 in Healthy Participants and Patients With IgA Nephropathy.Who this might be right forImmunoglobulin A Nephropathy Beijing Mabworks Biotech Co., Ltd. 130
Testing effectiveness (Phase 2)Looking for participantsNCT07616700What this trial is testingEvaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA NephropathyWho this might be right forIgA Nephropathy (IgAN) Haisco Pharmaceutical Group Co., Ltd. 73
Early research (Phase 1)Looking for participantsNCT07248865What this trial is testingCLYM116 in Normal Healthy VolunteersWho this might be right forHealthy Volunteers Climb Bio, Inc. 48